Closed System Transfer Devices Market to Reach $3.27 Billion, Globally, by 2030 at 15.4% CAGR: Allied Market Research

Rise in incidence of cancer, increase in number of oncology drug approvals, and surge in safety concerns of healthcare workers drive the growth of the global closed system transfer devices market

News provided by

Allied Market Research

Nov 22, 2021, 10:13 ET

PORTLAND, Ore., Nov. 22, 2021 /PRNewswire/ -- Allied Market Research published a report, titled, "Closed System Transfer Devices Market by Type (Membrane to Membrane and Needleless), By Technology (Diaphragm Based, Compartmentalized, and Filtration), and End User (Hospitals & Clinics, Oncology Centers, and Others): Global Opportunity Analysis and Industry Forecast, 2021–2030". According to the report, the global closed system transfer devices industry generated $823.58 million in 2020, and is anticipated to generate $3.27 billion by 2030, witnessing a CAGR of 15.4% from 2021 to 2030.

For Right Perspective and Competitive Insights, Get Sample Report at: https://www.alliedmarketresearch.com/request-sample/11637

Prime determinants of growth

Rise in incidence of cancer, increase in number of oncology drug approvals, and surge in safety concerns of healthcare workers drive the growth of the global closed system transfer devices market. However, high cost of implementation and lack of awareness hinder the market growth. On the other hand, increase in application of CSTDs in other therapeutic areas coupled with rise in safe usage initiative present new opportunities in the coming years.

Covid-19 Scenario

The outbreak of the Covid-19 pandemic had a negative impact on the global closed system transfer devices market.
As most of the clinics and hospitals across the globe were restructured to increase the hospital capacity for patients diagnosed with COVID-19, the demand for closed system transfer devices decreased.
The non-essential procedures took a potential backlog due to rapid rise of COVID-19 cases, which in turn, hampered the market.

The membrane to membrane segment to maintain its leadership status throughout the forecast period

Based on type, the membrane to membrane segment held the highest market share in 2020, accounting for more than two-thirds of the global closed system transfer devices market, and is estimated to maintain its leadership status throughout the forecast period. Moreover, the same segment is projected to manifest the highest CAGR of 16.2% from 2021 to 2030. This is due to their ease of operation, low risk of contamination, and increase in safety of healthcare workers due to double membrane system. The report also analyzes the needleless segment.

Do You Have Any Query Or Specific Requirement? Ask to Our Industry Expert: https://www.alliedmarketresearch.com/purchase-enquiry/11637

The hospitals & clinics sheet segment to maintain its lead position during the forecast period

Based on end user, the hospitals & clinics segment accounted for the largest share in 2020, contributing to around three-fourths of the global closed system transfer devices market, and is projected to maintain its lead position during the forecast period. Moreover, the same segment is expected to portray the largest CAGR of 16.0% from 2021 to 2030. This is due to rise in cancer cases leading to chemotherapy procedures. The report also discusses the oncology centers segment.

North America to maintain its dominance by 2030

Based on region, North America held the highest market share in terms of revenue 2020, accounting for more than one-third of the global closed system transfer devices market. This is due to rise in cancer cases and presence of key players across North America. However, the Asia-Pacific region is expected to witness the fastest CAGR of 17.7% from 2021 to 2030, owing to increase in prevalence of cancer, surge in R-&D activities for new oncology drugs, and rise in awareness for safety of the healthcare personnel.

Leading Market Players:-

B. Braun Holding GmbH & Co. KG
Baxter International
Becton, Dickinson and Company
Caragen Ltd.
Corvida Medical
Equashield
FIMI Opportunity Funds (Simplivia Healthcare)
ICU Medical
JCB Co Ltd. (JMS Co Ltd.)
Yukon Medical

Avenue Basic Plan | Library Access | 1 Year Subscription |

Sign up for Avenue subscription to access more than 12,000+ company profiles and 2,000+ niche industry market research reports at $699 per month, per seat. For a year, the client needs to purchase minimum 2 seat plan.

Request for 14 days free trial: https://www.alliedmarketresearch.com/avenue/trial/starter

"We have also published few syndicated market studies in the similar area that might be of your interest. Below are the report title for your reference, considering Impact of Covid-19 Over This Market which will help you to assess aftereffects of pandemic on short-term and long-term growth trends of this market."

Trending Reports in Healthcare Industry (Book Now with 10% Discount):

Ultrasound Devices Market - Global Opportunity Analysis and Industry Forecast, 2020–2028

Stents Market - Global Opportunity Analysis and Industry Forecast, 2019-2028

Prefilled Syringes Market - Global Opportunity Analysis and Industry Forecast, 2019-2028

Medical Device Outsourcing Market - Global Opportunity Analysis and Industry Forecast, 2019–2028

Sleep Aids Market - Global Opportunity Analysis and Industry Forecast, 2019–2028

Multiplex Assay Market - Global Opportunity Analysis and Industry Forecast, 2019–2028

Next Generation Sequencing (NGS) Market - Global Opportunity Analysis and Industry Forecast, 2019–2028

Medical Laser Market - Global Opportunity Analysis and Industry Forecast, 2019–2028

Surgical Robotics Market - Global Opportunity Analysis and Industry Forecast, 2019–2028

Surgical Equipment Market - Global Opportunity Analysis and Industry Forecast, 2019–2028

About Us

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

Pawan Kumar, the CEO of Allied Market Research, is leading the organization toward providing high-quality data and insights. We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

Contact:

David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
[email protected]
Web: https://www.alliedmarketresearch.com/reports-store/life-sciences
Follow Us on LinkedIn: https://www.linkedin.com/showcase/life-sciences-industry-research/